Epicondylitis News and Research

RSS
Review examines the role of biologic agents in management of shoulder and elbow problems

Review examines the role of biologic agents in management of shoulder and elbow problems

Ortho-ATI™ long term study showing effectiveness for tennis elbow published in prestigious American Journal of Sports Medicine

Ortho-ATI™ long term study showing effectiveness for tennis elbow published in prestigious American Journal of Sports Medicine

Clinical study shows long-term effectiveness of Orthocell’s Ortho-ATI™ for treatment resistant tennis elbow

Clinical study shows long-term effectiveness of Orthocell’s Ortho-ATI™ for treatment resistant tennis elbow

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Researchers analyze benefits of platelet-rich plasma therapy for tennis elbow

Researchers analyze benefits of platelet-rich plasma therapy for tennis elbow

Ultrasound boosts rheumatology clinical examination findings

Ultrasound boosts rheumatology clinical examination findings

SANUWAVE’s ESWT stimulates proliferation of cambium cells for bone generation

SANUWAVE’s ESWT stimulates proliferation of cambium cells for bone generation

SANUWAVE first quarter revenues decrease 5% to $238,540

SANUWAVE first quarter revenues decrease 5% to $238,540

SANUWAVE, CAN-med Healthcare enter distribution agreement for dermaPACE device

SANUWAVE, CAN-med Healthcare enter distribution agreement for dermaPACE device

USPTO issues patent to SANUWAVE's new method that produces acoustic shock waves

USPTO issues patent to SANUWAVE's new method that produces acoustic shock waves

SANUWAVE PACE technology reverses negative effects of ischemic, reperfusion injuries

SANUWAVE PACE technology reverses negative effects of ischemic, reperfusion injuries

SANUWAVE receives U.S. patent titled, 'Device for the Application of Acoustic Shock Waves'

SANUWAVE receives U.S. patent titled, 'Device for the Application of Acoustic Shock Waves'

SANUWAVE Health third quarter revenues decrease 42% to $161,678

SANUWAVE Health third quarter revenues decrease 42% to $161,678

SANUWAVE announces dermaPACE Phase III trial results on diabetic foot ulcers

SANUWAVE announces dermaPACE Phase III trial results on diabetic foot ulcers

SANUWAVE second quarter revenues increase 40%

SANUWAVE second quarter revenues increase 40%

USPTO upholds ten amended claims of SANUWAVE's '119 patent

USPTO upholds ten amended claims of SANUWAVE's '119 patent

SANUWAVE Health raises $4,102,660 from exercise of Options

SANUWAVE Health raises $4,102,660 from exercise of Options

Biomet Biologics completes enrollment in Recover Kit clinical trial for chronic tennis elbow

Biomet Biologics completes enrollment in Recover Kit clinical trial for chronic tennis elbow

SANUWAVE third quarter revenues increase to $278,000

SANUWAVE third quarter revenues increase to $278,000

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers

Patient follow-up complete in SANUWAVE's dermaPACE Phase III IDE trial for diabetic foot ulcers